Ch 7 - Neoplasia Flashcards
Normal cellular genes whose products promote cell proliferation
Proto-oncogenes
Mutated or overexpressed versions of proto-oncogenes that function autonomously, having lost dependence on normal growth promoting signals
Oncogenes
A protein encoded by an oncogene that drives increased cancer cell proliferation, which may result from a variety of aberrations
Oncoprotein
Activation of this tyrosine kinase by point mutations is often involved in myeloproliferative neoplasms
JAK2
This tyrosine kinase receptor of the EGF-receptor family is often affected by gene amplification in breast cancer.
HER2
Gene is ERBB2
Point mutations of this family of genes constitute the most common abnormality involving proto-oncogenes in human tumours
RAS
Transcription factor that is most commonly affected in cancer
MYC
Gain of function mutations in these cyclin/CDK genes promotes unregulated G1S progression
D cyclin genes and CDK4
Action of RB on E2F transcription factors when hypophosphorylated?
Inhibition of E2 transcription factors
How is RB inactivated by growth factors?
Hyperphosphorylation
Syndrome where individuals have inherited mutations in TP53
Li-Fraumeni syndrome
Inhibits p53 in normal healthy cells
MDM2
Protein of HPV that can inactivate RB and p53
E6
Germline mutations affecting this tumour suppressor gene are associated with familial adenomatous polyposis
APC
The target of APC which translocates to the nucleus and binds to TCF as part of the WNT signaling pathway
Beta-catenin
This gene encodes two protein products:
- p16/INK4a cyclin-dependent kinase inhibitor
- p14/ARF which activates the p53 pathway
Germline mutations of this are associated with familial forms of melanoma and sporadic mutations have been implicated in other cancers
CDKN2A
Encodes a component of a ubiquitin ligase complex that is responsible for degradation of hypoxia-induced factors (HIFs), transcription factors that alter gene expression in response to hypoxia
Mutations associated with renal cell carcinoma
VHL (von Hippel-Lindau)
Encodes a lipid phosphatase that is an important negative regulator of Pi3K/AKT signaling.
Germline mutations cause Cowden syndrome, an autosomal dominant disorder associated with a high risk of breast and endometrial carcinoma.
Biallelic loss of function common in diverse cancers.
PTEN
Term for the distinctive form of cellular metabolism displayed by cancer cells characterised by high levels of glucose uptake and increased conversion of glucose to lactose via the glycolytic pathway
Warburg effect
Oncometabolite resulting from IDH mutations
2-hydroxyglutarate
phenomenon whereby metastatic cells take root and survive within different tissues but fail to grow
tumour dormancy
Loss of this protein function is the preeminent source of genomic instability in cancers
p53
Syndrome due to inherited loss of function in genes involves in nucleotide excision repair. Associated with high risk of skin cancers
xeroderma pigmentosum
Patients with this syndrome have defects in the mismatch repair system. Genome shows microsatellite instability, characterised by changes in the length of short repeats throughout the genome
HNPCC (Lynch syndrome)
Inflammatory mediators thought to play a role in cancer cachexia
TNF, IL-1, IL-6
signs and symptoms that cannot readily be explained by the anatomic distribution of the tumour or by the elaboration of hormones indigenous to the tissue from which the tumour arose
Paraneoplastic syndromes